U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
September 20, 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
United States Endometriosis and Uterine Fibroids Markets, 2020-2024 & 2025-2030: Rise in Non-Invasive Drug Therapies Driving Growth, Online Pharmacies Set to Revolutionize Distribution
September 19, 2024 07:25 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type, By Route of Administration, By Distribution Channel, By...
Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie
September 18, 2024 04:14 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Women Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...
Gynecology Drugs Market Trends and Business Opportunities, Worldwide, 2024-2029
August 26, 2024 09:44 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
August 20, 2024 10:30 ET
|
Gynesonics
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
United States Women's Health Market, By Region, Competition, Forecast and Opportunities, 2019-2029F
July 09, 2024 10:39 ET
|
Research and Markets
Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "United States Women's Health Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
March 19, 2024 10:00 ET
|
Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
January 02, 2024 11:13 ET
|
Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 02, 2023 09:41 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
CORRECTION – Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 01, 2023 20:08 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure